Nantahala Capital Management - ADC THERAPEUTICS SA ownership

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of ADC THERAPEUTICS SA
ValueSharesWeighting
Q3 2023$230,674
-87.2%
257,162
-69.4%
0.02%
-88.6%
Q2 2023$1,806,000
+10.3%
840,0000.0%0.18%
+38.9%
Q1 2023$1,638,000
+75.3%
840,000
+245.3%
0.13%
+106.6%
Q4 2022$934,234243,2900.06%
Other shareholders
ADC THERAPEUTICS SA shareholders Q4 2023
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 1,680,149$24,681,0009.63%
Grosvenor Holdings, L.L.C. 1,517,212$22,288,0004.35%
Redmile Group, LLC 7,432,429$109,182,0003.41%
MPM BioImpact LLC 334,384$4,912,0001.32%
Indie Asset Partners, LLC 96,572$1,419,0001.07%
Eventide Asset Management 1,975,000$29,013,0000.46%
HHLR ADVISORS, LTD. 500,000$7,345,0000.15%
Virtus ETF Advisers LLC 19,193$282,0000.13%
Walleye Capital LLC 248,354$3,648,0000.10%
Matrix Capital Management Company, LP 400,000$5,876,0000.07%
View complete list of ADC THERAPEUTICS SA shareholders